收入
成本
利润
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenues | revenue | 100.43B | 6.17% |
| Other income | revenue | 32.00M | 14.29% |
| Operating income | profit | 4.68B | 38.71% |
| Total operating costs | cost | 95.75B | 4.97% |
| Aggregate | revenue | 4.71B | 38.51% |
| Cost of products sold | cost | 55.44B | 8.59% |
| Health care costs | cost | 29.36B | 0.77% |
| Operating expenses | cost | 10.94B | -0.71% |
| Income before income tax provision | profit | 3.94B | 50.48% |
| Interest expense, nonoperating | cost | 774.00M | -1.40% |
| Net income | profit | 2.96B | 65.94% |
| Income tax expense (benefit) | cost | 981.00M | 17.49% |
| Net income attributable to cvs health | profit | 2.94B | 65.43% |
| Net income (loss) attributable to noncontrolling interest | cost | 14.00M | 366.67% |
| Segment | Value | YoY |
|---|---|---|
| Health Services | 48.24B | 10.99% |
| Health Care Benefits | 35.97B | 3.34% |
| Pharmacy And Consumer Health | 31.99B | 0.24% |
| Segment | Value | YoY |
|---|---|---|
| Product | 62.23B | 7.90% |
| Service | 3.83B | 7.15% |
| Others | 34.37B | 3.07% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable, net | assets | 40.99B | |
| Inventories | assets | 17.77B | |
| Cash and cash equivalents | assets | 9.54B | |
| Other current assets | assets | 4.25B | |
| Investments | assets | 2.26B | |
| Total current assets | assets | 74.82B | |
| Goodwill | assets | 85.48B | |
| Long-term | assets | 32.41B | |
| Intangible assets, net | assets | 25.07B | |
| Operating lease right-of-use assets | assets | 14.74B | |
| Property and equipment, net | assets | 13.04B | |
| Other assets | assets | 7.42B | |
| Total assets | assets | 252.97B | |
| Total liabilities | liabilities | 175.34B | |
| Equity | liabilities | 77.64B | |
| Total current liabilities | liabilities | 86.41B | |
| Long-term debt | liabilities | 60.53B | |
| Long-term operating lease liabilities | liabilities | 13.33B | |
| Other long-term liabilities | liabilities | 6.71B | |
| Other long-term insurance liabilities | liabilities | 4.59B | |
| Deferred income taxes | liabilities | 3.77B | |
| Noncontrolling interests | liabilities | 181.00M | |
| Total cvs health shareholders’ equity | equity | 77.46B | |
| Treasury stock, common, value | equity | 36.71B | |
| Pharmacy claims and discounts payable | liabilities | 26.15B | |
| Accrued expenses and other current liabilities | liabilities | 22.26B | |
| Accounts payable | liabilities | 16.92B | |
| Health care costs payable | liabilities | 15.52B | |
| Current portion of long-term debt | liabilities | 2.58B | |
| Current portion of operating lease liabilities | liabilities | 1.90B | |
| Other insurance liabilities | liabilities | 1.07B | |
| Aggregate | equity | 114.16B | |
| Retained earnings | equity | 63.28B | |
| Common stock, par value $0.01: 3,200 shares authorized; 1,788 shares issued and 1,273 shares outstanding as of march 31, 2026 and 1,787 shares issued and 1,271 shares outstanding as of december 31, 2025 and capital surplus | equity | 50.68B | |
| Accumulated other comprehensive income (loss), net of tax | equity | 201.00M |
| Item | Value |
|---|---|
| Reconciliation of net income to net cash provided by operating activities: | 94.20B |
| Loss on assets held for sale | 526.00M |
| Income taxes paid, net | 337.00M |
| Interest paid, excluding capitalized interest, operating activity | -1.09B |
| Payments to suppliers and employees | -10.78B |
| Payments for insurance benefits | -28.40B |
| Payments for inventory and prescriptions dispensed by retail network pharmacies | -50.55B |
| Item | Value |
|---|---|
| Proceeds from sales and maturities of investments | 4.16B |
| Payment for (proceeds from) other investing activity | 7.00M |
| Payments to acquire businesses, net of cash acquired | -5.00M |
| Payments to acquire property, plant, and equipment | -849.00M |
| Payments to acquire investments | -4.19B |
| Item | Value |
|---|---|
| Proceeds from exercise of stock options | 103.00M |
| Payment, tax withholding, share-based payment arrangement | -9.00M |
| Other | -47.00M |
| Payments of dividends | -847.00M |
| Repayments of long-term debt | -1.52B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 8.71B |
| Cash and cash equivalents, end of period | 9.77B |
快速穿透 10-K/10-Q 复杂数据。通过利润表及资产负债表桑基图，与现金流量表瀑布图，一站式洞悉企业财务流向。
在左侧搜索公司并选择一份报告。
申请股票支持